JUN 25, 2019 11:16 AM PDT

Cholesterol Medication May Double Type 2 Diabetes Risk

WRITTEN BY: Nouran Amin

A research study examining thousands of patient’s health records found an association between prescribed cholesterol-lowering statins and the risk of developing type 2 diabetes. "The fact that increased duration of statin use was associated with an increased risk of diabetes -- something we call a dose-dependent relationship -- makes us think that this is likely a causal relationship," said Victoria Zigmont, who led the study as a graduate student in public health at The Ohio State University.

Retrieved from Ohio State University: Ohio State research found a higher risk of diabetes for people prescribed a cholesterol-lowering medication for heart disease prevention

Findings were published in Diabetes Metabolism Research and Reviews, and examined data from 4,683 patients who did not have diabetes and were candidates for statins. Results showed that statin use has in fact doubled the risk of Type 2 diabetes in comparison to those who did not take statin. Risk was even three times higher for those on statin therapy for more than two years.

"In addition, researchers conducting large prospective cohort studies should be considering how statins impact human health overall. They should consider both risks and benefits, not just the disease that is being treated by the specific drug," said co-author Steven Clinton, a professor of medicine and member of Ohio State's Comprehensive Cancer Center.

Statins are a class of drugs that treat patients at risk for a heart attack and stroke by reducing their cholesterol and blood pressure. According to federal estimates, more than 25 percent of middle-aged adults are prescribed cholesterol-lowering drugs.

"That said, statins are very effective in preventing heart attacks and strokes. I would never recommend that people stop taking the statin they've been prescribed based on this study, but it should open up further discussions about diabetes prevention and patient and provider awareness of the issue,” said Zigmont.

Learn more about statin therapy:

Source: Ohio State University

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
FDA Fast Tracks Vaccine for COVID-19
Biopharmaceutical company, Moderna, has announced that the US Food and Drug Administration has approved its experimental ...
MAY 28, 2020
Cancer
MAY 28, 2020
The Oncogenic Hazard of a Potential Alzheimer's Treatment
Breast cancer remains one of the most common cancers around the world. Triple-Negative Breast Cancer (TNBC) is a sub-typ ...
MAY 30, 2020
Cancer
MAY 30, 2020
Linking an Aggressive Tumor Factor to the Innate Immune Response
Epithelial Ovarian Cancer (EOC) is a cancer of the fallopian tubes with a low five-year survival rate with a tendency to ...
MAY 28, 2020
Drug Discovery & Development
MAY 28, 2020
Trial for Arthritis Drug with Remdesivir to Beat COVID-19
Montefiore Health System and Albert Einstein College of Medicine in New York have teamed up to see how well remdesivir, ...
JUN 16, 2020
Microbiology
JUN 16, 2020
Dexamethasone Hailed as Effective COVID-19 Treatment
The pandemic virus SARS-CoV-2, which causes COVID-19, has killed more than 438,000 people worldwide since it emerged lat ...
JUN 18, 2020
Drug Discovery & Development
JUN 18, 2020
FDA Cancels Emergency Approval for Hydroxychloroquine
The US Food and Drug Administration (FDA) has decided to cancel emergency use authorization for Hydroxychloroquine and C ...
Loading Comments...